The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX (mFOLFIRINOX) in previously untreated patients (pts) with advanced gastrointestinal malignancies.
Manish Sharma
No relevant relationships to disclose
Daniel Virgil Thomas Catenacci
No relevant relationships to disclose
Theodore Karrison
No relevant relationships to disclose
Kenisha Allen
No relevant relationships to disclose
Jaclyn D Peterson
No relevant relationships to disclose
Robert de Wilton Marsh
No relevant relationships to disclose
Mark Kozloff
No relevant relationships to disclose
Blase N. Polite
No relevant relationships to disclose
Hedy Lee Kindler
No relevant relationships to disclose